Alec Stranahan
Stock Analyst at B of A Securities
(0)
# 2642
Out of 5,298 analysts
31
Total ratings
29.41%
Success rate
8.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Upgrades: Buy | 42 42 | 16.48 | 154.85% | 1 | Mar 28, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Neutral | 14 12 | 4.67 | 156.96% | 5 | Mar 5, 2025 | |
CADL Candel Therapeutics | Initiates Coverage On: Buy | 15 | 5.24 | 186.26% | 1 | Feb 7, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 28 25 | 7.71 | 224.25% | 4 | Jan 7, 2025 | |
CRBU Caribou Biosciences | Maintains: Buy | 13 11 | 0.79 | 1292.41% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 5 | 1.22 | 309.84% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 6 | 1.95 | 207.69% | 2 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 32.89 | 67.22% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 5.6 | 221.43% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 178.31 | -21.49% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 8.91 | 371.38% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 39.3 | -84.73% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 0.85 | 488.24% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 43.11 | 4.38% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |